|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910791776703321 |
|
|
Titolo |
Challenges and opportunities in using residual newborn screening samples for translational research [[electronic resource] ] : workshop summary / / Steve Olson and Adam C. Berger, rapporteurs ; Roundtable on Translating Genomic-Based Research for Health, Board on Health Sciences Policy, Institute of Medicine of the National Academies |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, D.C., : National Academies Press, 2010 |
|
|
|
|
|
|
|
ISBN |
|
0-309-17713-8 |
1-282-91713-7 |
9786612917134 |
0-309-15955-5 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (85 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
OlsonSteve <1956-> |
BergerAdam C |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Genetic disorders - Diagnosis |
Newborn infants - Diseases - Diagnosis |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
""Front Matter""; ""Reviewers""; ""Acknowledgments""; ""Contents""; ""Abbreviations and Acronyms""; ""1 Introduction""; ""2 Newborn Screening as a Public Health Program""; ""3 Uses of Residual Newborn Screening Samples in Research""; ""4 Concerns About the Use of Residual Newborn Screening Samples""; ""5 Review and Consent in the Use of Residual Newborn Screening Samples""; ""6 Parental and Public Education""; ""7 Workshop Overview and Wrap-Up""; ""References""; ""Appendix A: Workshop Agenda""; ""Appendix B: Speaker Biographical Sketches"" |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
"Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research." |
|
|
|
|
|
|
|